Santiago Mercadal

16PUBLICATIONS
56CO-AUTHORS
Gene and molecular therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersDisease surveillance
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Oct 17, 2024
Outcomes After Brexucabtagene Autoleucel Administered as a Standard Therapy for Adults With Relapsed/Refractory B-Cell ALL.

Gregory W Roloff, Ibrahim Aldoss, Noam E Kopmar

|Mar 01, 2024
Allogeneic stem cell transplantation and CAR-T in B-cell Non-Hodgkin Lymphoma: a two-center experience and review of the literature.

Santiago Mercadal, Alberto Mussetti, Catherine J Lee

|May 29, 2023
Infectious complications following CAR-t cell therapy for B cell non-Hodgkin lymphoma: a single-center experience and review of the literature.

Santiago Mercadal, Carlos A Gomez, Catherine J Lee

|Oct 19, 2022
Early progression in follicular lymphoma in the absence of histological transformation or high-risk Follicular Lymphoma International Prognostic Index still has a favourable outcome.

Ana Muntañola, Pablo Mozas, Santiago Mercadal

|Aug 27, 2022
Link between disease status at 24 months and mortality in follicular lymphoma.

Aino Rajamäki, Mika Hujo, Reijo Sund

|Jun 08, 2022
Ponatinib, chemotherapy, and transplant in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia.

Josep-Maria Ribera, Olga García-Calduch, Jordi Ribera

Pageof 3

Frequent Collaborators

4 joint publications

Juan-Manuel Sancho

3 joint publications

Laura Magnano

3 joint publications

Pau Montesinos

3 joint publications

Alberto Orfao